Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024.

Latest news · 05 November 2024. Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first ...

Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to USD 29.8 billion in the first nine months of 2024.

2 дня назад · Driving Novo Nordisk's growth is its control of 65% of the global market for GLP-1 drugs, which treat conditions like type 2 diabetes as well as ...

Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to USD 29.8 billion in the first nine months of 2024.

Investors look to weight loss drugs to boost Novo Nordisk growth ... Researchers looked at the composition of online purchases of semaglutide, the popular drug ...

Find the latest Novo Nordisk A/S (NVO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Novo Nordisk has a share of more than half of the global market for the class of drugs that treat diabetes and obesity.

Here you can access our news and press materials. You can also find videos about the Foundation's history and links to other websites.